IN2014DN07927A - - Google Patents
Info
- Publication number
- IN2014DN07927A IN2014DN07927A IN7927DEN2014A IN2014DN07927A IN 2014DN07927 A IN2014DN07927 A IN 2014DN07927A IN 7927DEN2014 A IN7927DEN2014 A IN 7927DEN2014A IN 2014DN07927 A IN2014DN07927 A IN 2014DN07927A
- Authority
- IN
- India
- Prior art keywords
- biorelevant
- fasted state
- fatty acid
- sodium
- homogeneous
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 3
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 150000004665 fatty acids Chemical class 0.000 abstract 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 2
- 241000282472 Canis lupus familiaris Species 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 abstract 1
- 239000003833 bile salt Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 abstract 1
- 229940045946 sodium taurodeoxycholate Drugs 0.000 abstract 1
- YXHRQQJFKOHLAP-FVCKGWAHSA-M sodium;2-[[(4r)-4-[(3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 YXHRQQJFKOHLAP-FVCKGWAHSA-M 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
- G09B23/30—Anatomical models
- G09B23/303—Anatomical models specially adapted to simulate circulation of bodily fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
- G09B23/30—Anatomical models
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pure & Applied Mathematics (AREA)
- Business, Economics & Management (AREA)
- Mathematical Physics (AREA)
- Mathematical Optimization (AREA)
- Mathematical Analysis (AREA)
- Educational Administration (AREA)
- Computational Mathematics (AREA)
- Educational Technology (AREA)
- Algebra (AREA)
- Medical Informatics (AREA)
- Theoretical Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12162548.7A EP2645099A1 (en) | 2012-03-30 | 2012-03-30 | Biorelevant compositions |
| PCT/EP2013/056945 WO2013144374A1 (en) | 2012-03-30 | 2013-04-02 | Biorelevant compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN07927A true IN2014DN07927A (enExample) | 2015-05-01 |
Family
ID=48143258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN7927DEN2014 IN2014DN07927A (enExample) | 2012-03-30 | 2013-04-02 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150064794A1 (enExample) |
| EP (2) | EP2645099A1 (enExample) |
| JP (1) | JP6348480B2 (enExample) |
| KR (1) | KR20140144255A (enExample) |
| CN (1) | CN104582689A (enExample) |
| BR (1) | BR112014024256A8 (enExample) |
| CA (1) | CA2867638A1 (enExample) |
| IN (1) | IN2014DN07927A (enExample) |
| MX (1) | MX357927B (enExample) |
| NZ (1) | NZ700064A (enExample) |
| WO (1) | WO2013144374A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014000547B1 (pt) * | 2011-08-23 | 2021-11-09 | Kythera Biopharmaceuticals, Llc | Composição aquosa estável em precipitação |
| WO2019199238A1 (en) * | 2018-04-09 | 2019-10-17 | Vet Products Research And Innovation Center Company Limited | Inorganic mineral entrapped in nanoparticle production method thereof |
| GB201809627D0 (en) * | 2018-06-12 | 2018-07-25 | Biorelevant Com Ltd | Methods for preparing buffer solutions suitable for in vitro drug dissolution testing, drug solubility testing and/or drug profiling |
| GB201904757D0 (en) * | 2019-04-04 | 2019-05-22 | Biorelevant Com Ltd | Biorelevant composition |
| KR20220027971A (ko) * | 2019-06-28 | 2022-03-08 | 얀센 파마슈티카 엔.브이. | 생체관련 용해 매질 |
| EP4107742A1 (de) | 2020-02-19 | 2022-12-28 | Bayer Aktiengesellschaft | Vorhersage von formulierungseigenschaften |
| GB202112975D0 (en) | 2021-09-10 | 2021-10-27 | Biorelevant Com Ltd | Biorelevant dissolution compositions with reproducible spectral profiles |
| GB202405714D0 (en) * | 2024-04-23 | 2024-06-05 | Biorelevant Com Ltd | Biorelevant compositions and media for in vitro testing |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4874795A (en) * | 1985-04-02 | 1989-10-17 | Yesair David W | Composition for delivery of orally administered drugs and other substances |
| GB8909022D0 (en) * | 1989-04-20 | 1989-06-07 | Cortecs Ltd | Pharmaceutical compositions |
| US6040188A (en) * | 1997-11-18 | 2000-03-21 | The Regents Of The University Of California | In vitro gastrointestinal mimetic protocol for measuring bioavailable contaminants |
| IT1296914B1 (it) * | 1997-12-01 | 1999-08-03 | Maria Rosa Gasco | Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera |
| WO2003042392A1 (en) * | 2001-11-15 | 2003-05-22 | Phares Pharmaceutical Research N.V. | Standardised phospholipid mixtures |
| EP1734937A1 (en) * | 2004-03-26 | 2006-12-27 | Cell Therapeutics Europe S.R.L. | Nanoparticle formulations of platinum compounds |
| GB0522942D0 (en) * | 2005-11-10 | 2005-12-21 | Leigh Steven | Dissolution composition |
| JP2009524640A (ja) * | 2006-01-27 | 2009-07-02 | ダニスコ エー／エス | 肥満及びそれに関連する疾患の治療及び予防のためのプロバイオティック微生物の使用 |
| WO2008040799A2 (en) | 2006-10-06 | 2008-04-10 | Boehringer Ingelheim International Gmbh | Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release |
-
2012
- 2012-03-30 EP EP12162548.7A patent/EP2645099A1/en not_active Ceased
-
2013
- 2013-04-02 WO PCT/EP2013/056945 patent/WO2013144374A1/en not_active Ceased
- 2013-04-02 IN IN7927DEN2014 patent/IN2014DN07927A/en unknown
- 2013-04-02 NZ NZ700064A patent/NZ700064A/en not_active IP Right Cessation
- 2013-04-02 BR BR112014024256A patent/BR112014024256A8/pt not_active Application Discontinuation
- 2013-04-02 EP EP13717734.1A patent/EP2830592A1/en not_active Withdrawn
- 2013-04-02 CA CA2867638A patent/CA2867638A1/en not_active Abandoned
- 2013-04-02 CN CN201380018498.8A patent/CN104582689A/zh active Pending
- 2013-04-02 KR KR1020147030491A patent/KR20140144255A/ko not_active Ceased
- 2013-04-02 JP JP2015502383A patent/JP6348480B2/ja not_active Expired - Fee Related
- 2013-04-02 MX MX2014011789A patent/MX357927B/es active IP Right Grant
- 2013-04-02 US US14/389,701 patent/US20150064794A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20150064794A1 (en) | 2015-03-05 |
| EP2645099A1 (en) | 2013-10-02 |
| MX357927B (es) | 2018-07-27 |
| MX2014011789A (es) | 2015-06-03 |
| CA2867638A1 (en) | 2013-10-03 |
| EP2830592A1 (en) | 2015-02-04 |
| BR112014024256A2 (enExample) | 2017-06-20 |
| KR20140144255A (ko) | 2014-12-18 |
| WO2013144374A1 (en) | 2013-10-03 |
| BR112014024256A8 (pt) | 2018-02-06 |
| JP2015524913A (ja) | 2015-08-27 |
| JP6348480B2 (ja) | 2018-06-27 |
| CN104582689A (zh) | 2015-04-29 |
| NZ700064A (en) | 2016-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN07927A (enExample) | ||
| Dubois-Brissonnet et al. | The biofilm lifestyle involves an increase in bacterial membrane saturated fatty acids | |
| Alkalbani et al. | Assessment of yeasts as potential probiotics: A review of gastrointestinal tract conditions and investigation methods | |
| WO2012125937A3 (en) | Glycosyl hydrolase enzymes and uses thereof for biomass hydrolysis | |
| MY160275A (en) | Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids | |
| GB201212223D0 (en) | Electrical connectors | |
| MA35195B1 (fr) | Compositions lipidiques algales, leurs procédés de préparation et leurs utilisations | |
| RU2010129985A (ru) | Композиции питательного порошка и детской питательной смеси (варианты) | |
| MX2010006197A (es) | Composicion nutricional enterica liquida con alto contenido de energia. | |
| WO2014006261A3 (es) | Micropartículas para encapsulación de probióticos, su obtención y usos | |
| AR077860A1 (es) | Productos horneados de humedad intermedia y larga vida | |
| DK1996028T3 (da) | Faste enzymformuleringer og fremgangsmåde til deres fremstilling | |
| BR112013032595A2 (pt) | produtos para o consumidor com partículas revestidas que compreendem lipase | |
| Song et al. | Nanocomposite of half-fin anchovy hydrolysates/zinc oxide nanoparticles exhibits actual non-toxicity and regulates intestinal microbiota, short-chain fatty acids production and oxidative status in mice | |
| WO2012032416A3 (en) | Comestible emulsions | |
| PH12013501337A1 (en) | Novel preparation of an enteric release system | |
| WO2012028526A3 (en) | Tetranectin-apolipoprotein a-i, lipid particles containing it and its use | |
| MY199653A (en) | Encapsulated nutritional and pharmaceutical compositions | |
| EA200801813A1 (ru) | Содержащие жирные кислоты побочные продукты и способы их применения | |
| MX355131B (es) | Emulsion de aceite en agua estable al calor. | |
| EP2613636A4 (en) | Dietary supplement and methods of use thereof | |
| ATE453332T1 (de) | Pulverzusammensetzungen | |
| MX2011007222A (es) | Composicion nutricional para infantes. | |
| Zhou et al. | Dairy processing affects the gut digestion and microecology by changing the structure and composition of milk fat globules | |
| WO2005112891A3 (en) | Encapsulated transfer factor compositions and methods of use |